UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

Contributed by: PR Newswire

Tags

UTime-Expansion

More Like This

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

Remarkable Announcement on Significant Fluctuation of the UTime's Share Price

UTime Limited to Participate in International Medical Fairs and Medical Conferences

UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration

PR Newswire associated0

Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan

ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA

PR Newswire associated0

UST Announces Strategic Transaction with Bain Capital to Propel Next Phase of Growth

About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron